A Study to Investigate the Effect of CYP3A4 Inhibition on the Single Dose Pharmacokinetics of ASTX660 and the Effect of a Single Dose of ASTX660 on the Pharmacokinetics of the CYP3A4 Substrate Midazolam
Clinical trial NCT04411030 · COMPLETED
Trial details
- NCT number
- NCT04411030
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2020-08-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.